Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT00985907 · TERMINATED
Trial details
- NCT number
- NCT00985907
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-28
- Primary completion
- 2008-10-07
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.